We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream

By LabMedica International staff writers
Posted on 28 Feb 2025

Bacteremia, also known as blood poisoning, occurs when bacteria manage to overcome the body's immune defenses. More...

This condition can progress into sepsis, a serious illness that is responsible for over a third of hospital-related deaths each year. While individuals are frequently exposed to bacteria from the environment, they often fight off these infections without experiencing this deadly progression. Scientists are working to understand how bacteria spread throughout the body to cause systemic infections, with the ultimate goal of halting this process before it escalates.

Researchers at U-M Medical School (Ann Arbor, MI, USA) have been investigating this issue, focusing on gram-negative bacteria such as Klebsiella pneumoniae, a common cause of pneumonia-related bacteremia. In their previous studies, they identified three stages in the spread of bacteria: initial infection at a site like the lungs, entry into the bloodstream, and replication while avoiding filtration by the liver and spleen. Traditionally, bacterial infections are analyzed by culturing tissue and counting the resulting bacteria. While it’s easy to measure the initial infection phase by observing how bacteria invade the lungs, and similarly, the third phase by assessing how bacteria survive in the liver and spleen, the transition from the lungs into the bloodstream has been difficult to track.

Using an innovative barcoding system, the researchers labeled bacteria with short DNA sequences in mouse models and employed computer analysis to track the movement of K. pneumoniae throughout the body. They initially hypothesized that the bacteria would replicate in the lungs until they overwhelmed the local immune defenses, eventually spilling into the bloodstream. This type of spread, which they called metastatic dissemination, was observed in some mice. However, they also uncovered an unexpected pattern. About half of the mice showed this metastatic pattern, while the other half exhibited a form of bacterial spread where the bacteria entered the bloodstream on their own without first replicating in large numbers, a process they termed direct dissemination.

The findings, published in Nature Communications, revealed that the metastatic pathway was associated with a more severe infection compared to the direct dissemination route. Moreover, over time, the infection tended to follow the metastatic pattern. The discovery of the direct route suggests that bacteria might be establishing low-level reservoirs in other parts of the body, which could offer new targets for treating blood infections. Additionally, the researchers introduced mutations in both the K. pneumoniae bacteria and the mice, which affected the mode of bacterial dissemination. This hinted that the interaction between the bacteria and the host’s immune system could play a key role in determining the course of the infection.

“The project began with a very basic question—how does bacteria leave the lungs—that we have now provided some insight into, closing a significant gap in our knowledge,” said Michael Bachman, M.D., Ph.D., clinical associate professor of pathology and microbiology and immunology at U-M Medical School.


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA480
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The SimpleScreen CRC platform uses multiomics, AI, and machine learning to analyze blood-based signals and detect cancer-associated patterns (Photo courtesy of Freenome)

Blood Test Achieves Improved Detection of Advanced Precancerous Colorectal Lesions

Colorectal cancer is the second-leading cause of cancer-related death in the United States, yet screening uptake remains suboptimal. More than 50 million eligible adults are not up to date with recommended... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.